Clinical Trials Browser

Phase 2 × L-BLP25 × Genitourinary × Clear all

NCT01496131 2018-03-09

Tecemotide (L-BLP25) in Prostate Cancer

Phase 2 Completed

28 enrolled 9 charts

Prostatic Neoplasms